Exam II Genetics
2/19/24
Next Generation Sequencing
Pyrosequencing - when a dNTP is incorporated into a growing DNA strand, two covalently linked phosphates (pyrophosphate, PPi) are released
pyrosequencing machines detect light every time these 2 phosphates are released and react chemically with enzymes to form ATP and give off life
dNTPs area one at a time, and removed if not incorporated into sequencing reaction
refer to textbook
Site-specific Mutagenesis
Sit specific mutagenesis - in vitro targeting of specific cloned genes
Use PCR w/ mutant (M) primers
Heat products and allow to re-anneal (some A will bond with B)
DNA polymerase fill in gaps
Amplified again with primer 1 & 3 for full-length molecule with mutation
transform into cell - replaces wild type
Gene knockouts
How a gene affects human health
Clone human gene - then clone it in mouse
Site-specific mutagenesis of mouse gene
Inject mutant gene into mouse embryos — replaces one wild type gene in mouse cells
Screen baby mice for mutation — knockout mice heterozygotes (+/-)(One normal wild type copy & mutant copy)
Interbreeding of heterozygotes can produce homozygote knockouts (only mutant copies leftover)
Polymorphism
The quality or state of being able to assume different forms
In species — existence of several forms (shape, size, color) regardless of sex
DNA polymorphism: One of two or more alternative forms of an allele from a chromosomal locus resulting from differences in DNA sequences or numbers of tandem repeats-not necessarily a gene-can be anywhere
DNA marker: a known DNA sequence, often of DNA polymorphisms—best ones are unique in the genome, STS (sequence-tagged sites)
Classes of DNA polymorphisms: SNPs (single-nucleotide polymorphisms), STRs (Short-tandem repeats), and VNTRs (variable number of tandem repeats)
SNPs ~1 every 1 kbp (45% of genes are heterozygous) - 12 million SNPs identified in humans
Generally each gene is STS site
SNOS cause a single point mutation at a site—most common DNA polymorphism (95% of DNA variation)
Can be harmful if they occur in coding genes, or regulatory regions—detection is important
SNPS can sometimes affect restriction sites, thus causing Restriction Fragment Length Polymorphisms—restriction enzyme generated fragments of different lengths
RFLPs can be detected with Southern blot or PCR
Southern blotting
Analysis determines arrangement and location of restriction sites
Genomic DNA is digested with several restriction enzymes, produces many fragments
Fragments separated by size with gel electrophoresis
DNA fragments transferred to a membrane filter—arranged exactly as they are on the gel
a labeled probe (radioactive or chemiluminescence) binds to DNA interest
Southern blot: DNA
Northern blot: RNA
Western blot: Proteins
Oligonucleotide: Short piece of RNA or DNA
Used to find SNPs, as SNP do not attach to restriction sites
Make an oligonucleotide that matches normal allele perfectly
Isolate target DNA and mix with oligo-
Microarrays: Developed in 1990s, ordered grid of probe single-stranded DNA molecules of known sequence (with many SNP combinations) fixed to a microchip
Use unlabeled probes (fixed to substrate) and free target DNA from target organisms with colored dyes
Ex. cDNA targets have red or green des, so red or green spots on microarray indicate hybridized to indicate those probes
Yellow means both hybridized, other colors indicate degrees of hybridization
cDNA = DNA synthesized by reverse transcriptase from mRNA
Transcriptomics
Microarrays now largely replaced by transcriptomics
Study of the transcriptome: the complete set of RNA transcripts produced by the genome of a specific cell or organism at a specific time, or under a specific set of conditions
Transcriptome is dynamic/constantly changing
Entire transcriptome can be sequenced with next-gen sequencing (specifically RNA-seq. in this case) to understand what genes are turned off/on)
STRS, SSRs or microsatellites
Short tandem repeats or simple sequence repeats: 2-6 bp of DNA sequences repeated tandemly up to about 100x in the genome
CCTCCTCCTCCTCCTCCT
High rate of mutation because:
are in noncoding regions of the genome
often mismatched during replication, considered “junk DNA”
STRs make up 10% of mouse genome, lots of data
With PCR, often used in population-level genetics studies/identify relationship to individuals
PCR amplifies region with STRs — gel electrophoresis used to see fragment sizes
VNTRs or minisatellites
Variable-Number Tandem repeats
Similar to STRs but repeating unit is 7 - 20
Larger length of units = southern blot used more often than PCR
Can be multiple VNTR copies scattered around genome
VNTRs first use of DNA data to exonerate someone in a murder trial in 1988
DNA fingerprinting: Takes advantage of DNA polymorphisms to identify individuals for forensics
DNA from blood, RE isolated segment with marker, VNTR probes used with s. blot to obtain profile of everybody
Everybody is heterozygous—but baby matches one allele from mom and one from dad
Gene therapy
Gene therapy is mostly for somatic cells to correct diseases present
Commonly for disorders with single mutation for which a normal clone is available
procedure — take out cells, introduce normal gene (transgene) with virus vectors into them (now a transgenic cell). replace in body.
sometimes normal gene replaces mutant in cell, ither tines is inserted elsewhere in the genome and must be expressed to work
Pedigree
Pedigree: pictorial representation of a family,
tracks inheritance of one or more characteristics
Proband: person for whom the pedigree is initiated
Autosomal Recessive traits:
Appear equally in male and females
skip gens
Consanguinity: Affected people on mating among closely related members
Genetic testing
Genetic testing: identifies mutations in key genes responsible for disease
Does not always work:
Gene for disease not found in genome
Gene has many mutations
Presence of one gene doe4s not always result in disease
Many diseases are polygenic
Carrier detection (heterozygote screening): genetic testing of adults to calculate probability of baby having disease, uses blood
Cell-free (cfDNA) screening: Blood test of DNA fragments from placenta at 10 weeks—looks for chromosomal abnormalities and sex of baby
Prenatal diagnosis: Amniocentesis is done to perform genetic testing—now can be done on embryos before implantation
Newborn screening: testing newborn babies for genetic disease using blood sample